Can Imatinib/Gleevec be taken with other medicines?

Imatinib/Gleevec (Imatinib), as a tyrosine kinase inhibitor, is often used to treat chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors. Since these diseases usually have a chronic course, it is normal for patients to take medications for a long time, so it is inevitable that they will be used in combination with other drugs. However, imatinib is mainly metabolized in the liver by the CYP3A4 enzyme, which exposes it to the risk of potential drug interactions with many common drugs and must be handled with caution.

When combined with certain antibiotics, antifungals, antiepileptic drugs, antiviral drugs or psychotropic drugs, the blood concentration of imatinib may be enhanced or inhibited, thereby affecting the efficacy or side effects. For example, CYP3A4 inhibitors such as ketoconazole may increase the concentration of imatinib, resulting in an increased risk of toxic reactions, while enzyme inducers such as carbamazepine and rifampicin may reduce the efficacy of the drug, leading to treatment failure. In addition, imatinib may itself affect the metabolism of other drugs, causing changes in their concentrations and posing potential risks. For example, the efficacy of certain antihypertensive drugs, anticoagulants, or heart rhythm drugs may be altered by interference from imatinib. Therefore, it is important to consult a hematologist or oncologist and have a medication review and evaluation by a pharmacist before coadministration.

In addition, supplements containing calcium, magnesium, iron and other ingredients may also affect the absorption of imatinib. It is recommended that the dosage interval be controlled to more than 1 to 2 hours to avoid interference with absorption. If patients are taking anti-gastric drugs, such as proton pump inhibitors or H2 receptor antagonists, they should also consult their doctor whether they need to adjust the medication time or switch to a drug that has less interference with imatinib. For patients with chronic diseases such as hypertension, diabetes, heart disease, etc., combined medication should follow a professional evaluation process to avoid medication conflicts.

Reference materials:https://www.gleevec.com/